Filtered By:
Procedure: Lung Transplant
Therapy: Palliative
This page shows you your search results in order of date.
Order by Relevance | Date
Total 62 results found since Jan 2013.
Transplant oncology: multivisceral transplantation for neuroendocrine tumor and liver metastasis
Curr Opin Organ Transplant. 2023 Apr 11. doi: 10.1097/MOT.0000000000001063. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Neuroendocrine tumor (NET) liver metastatic lesions are often multiple and found to be unresectable. Rationale of multivisceral transplantation (MVT: liver-pancreas-intestine transplantation) include radical and complete resection of primary, visible and invisible metastatic tumors by removing all abdominal organs and the lymphatic system. This review aims to describe the concept of MVT for NET and neuroendocrine liver metastasis (NELM), patient selection, timing of MVT, and posttransplant outcomes a...
Source: Current Opinion in Organ Transplantation - April 11, 2023 Category: Transplant Surgery Authors: Shunji Nagai Source Type: research
Idiopathic Pulmonary Fibrosis: State of the Art for 2023
Eur Respir J. 2023 Jan 26:2200957. doi: 10.1183/13993003.00957-2022. Online ahead of print.ABSTRACTIdiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease characterized by worsening respiratory symptoms and physiologic impairment. Increasing awareness of the clinical manifestations of IPF, more widespread use of computed tomography scans, and other potential factors have contributed to a rising prevalence of IPF over the last two decades, especially among people over the age of 65. Significant advances in the understanding of the pathobiology of IPF have emerged, and multiple genetic and nongenetic contr...
Source: Respiratory Care - January 26, 2023 Category: Respiratory Medicine Authors: Anna J Podolanczuk Carey C Thomson Martine Remy-Jardin Luca Richeldi Fernando J Martinez Martin Kolb Ganesh Raghu Source Type: research
Current best clinical practices for monitoring of interstitial lung disease
Expert Rev Respir Med. 2022 Dec 26. doi: 10.1080/17476348.2022.2162504. Online ahead of print.ABSTRACTINTRODUCTION: Interstitial lung diseases (ILDs) are a heterogeneous group of inflammatory and/or fibrotic conditions with variable outcome and often a dismal prognosis. Since many ILDs are progressive in nature, monitoring of signs and symptoms of progression is essential to inform treatment decisions and patient counseling. Monitoring of ILDs is a multimodality process and includes all aspects of the disease e.g., measurement of pulmonary function and exercise capacity, symptom registration and quality of life (QoL), imag...
Source: Respiratory Care - December 26, 2022 Category: Respiratory Medicine Authors: Elisabeth Bendstrup Sissel Kronborg-White Janne M øller Thomas Skovhus Prior Source Type: research
Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
CONCLUSIONS: The present study is the first one focused on antineoplastic chemotherapy in LT recipients. Our results suggest that immunosuppressive drugs and antineoplastic chemotherapy can be managed satisfactorily in most cases but this need confirmation from larger cohorts. This article is protected by copyright. All rights reserved.PMID:36394373 | DOI:10.1111/ctr.14841
Source: Clinical Lung Cancer - November 17, 2022 Category: Cancer & Oncology Authors: Antoine Coupier Yves Gallien Olivier Boillot Thomas Walter Olivier Guillaud M élanie Vallin Elsa Thimonier Domitille Erard J érôme Dumortier Source Type: research
Multidisciplinary Care and Prognosis in Patients With COPD and Interstitial Lung Disease Prescribed Long-Term Oxygen Therapy
CONCLUSIONS: This study found that subjects prescribed LTOT had poor transplant-free survival after initiation, which was significantly worse for those with ILD compared to those with COPD. Despite their poor overall survival, worse than many cancers, only a minority were referred for palliative care input. Referrals to pulmonary rehabilitation were also suboptimal. This patient population had complex care needs requiring multidisciplinary management. Appropriate and early referrals to palliative care and improved care coordination for this complex group of patients are key areas for improvement in clinical practice.PMID:3...
Source: Respiratory Care - May 3, 2022 Category: Respiratory Medicine Authors: Amelia Ca Harrison Julien F Robinson Laura Tu Christine F McDonald Yet Hong Khor Source Type: research
Equity of timely access to liver and stomach cancer surgery for Indigenous patients in New Zealand: a national cohort study
CONCLUSIONS: We found that (a) access to liver transplant for Māori is lower than for Europeans; (b) Māori with stomach cancer appear more likely to require the type of palliation consistent with gastric outlet obstruction; and (c) differential timing of first stomach cancer surgery between Māori and European patients. However, we may also be cautiously encouraged by the fact that differences in overall access to curative surgical treatment were either marginal (liver) or absent (stomach).PMID:35487720 | DOI:10.1136/bmjopen-2021-058749
Source: Cancer Control - April 29, 2022 Category: Cancer & Oncology Authors: Jason Gurney Diana Sarfati James Stanley Clarence Kerrison Jonathan Koea Source Type: research
Clinician Ethical Perspectives on Extracorporeal Membrane Oxygenation in Practice
CONCLUSION: Adequate informed consent for ECMO is a major ethical challenge, and the content of these discussions varies. Use of categorical exclusion criteria and withdrawal of ECMO if a patient cannot be liberated from it differ among departments and institutions.PMID:34414798 | DOI:10.1177/10499091211041079
Source: The American Journal of Hospice and Palliative Care - August 20, 2021 Category: Palliative Care Authors: Gina M Piscitello Rene S Bermea John W Stokes Whitney D Gannon Anthony J Kanelidis Megan Konopka Claire Shappell Laura K Frye Patrick G Lyons Mark Siegler William F Parker Source Type: research
A descriptive evaluation of causes of death in venovenous extracorporeal membrane oxygenation
This study demonstrated that the most common cause of death in patients supported with VV ECMO was removal of LST due MSOF. Acute hemorrhage (systemic or intracranial) was not found to be a common cause of death in our patient population.PMID:34365847 | DOI:10.1177/02676591211035938
Source: Perfusion - August 9, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Sagar B Dave Kristopher B Deatrick Samuel M Galvagno Michael A Mazzeffi David J Kaczorowski Ronson J Madathil Raymond Rector Ali Tabatabai Daniel J Haase Daniel Herr Thomas M Scalea Jay Menaker Source Type: research
